Research Analysts’ downgrades for Saturday, September 9th:

Analog Devices (NASDAQ:ADI) was downgraded by analysts at BidaskClub from a buy rating to a hold rating.

Ares Management L.P. (NYSE:ARES) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

GATX Corporation (NYSE:GATX) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

GasLog Partners (NYSE:GLOP) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

Globalstar (NYSEMKT:GSAT) was downgraded by analysts at BidaskClub from a sell rating to a strong sell rating.

Level 3 Communications (NYSE:LVLT) was downgraded by analysts at BidaskClub from a sell rating to a strong sell rating.

Monogram Residential Trust (NYSE:MORE) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

Sibanye Gold Limited (NYSE:SBGL) was downgraded by analysts at BidaskClub from a strong-buy rating to a buy rating.

Sinovac Biotech (NASDAQ:SVA) was downgraded by analysts at BidaskClub from a buy rating to a hold rating.

Wendy’s Company (The) (NASDAQ:WEN) was downgraded by analysts at BidaskClub from a hold rating to a sell rating.

Yirendai (NYSE:YRD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Yirendai Ltd. is involved in the online consumer finance business. Yirendai Ltd. is based in Beijing, China. “

Yanzhou Coal Mining Co (NASDAQ:YZCAY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Yanzhou Coal Mining Company Limited is engaged in the underground mining of prime quality, low-sulfur coal from its mines in Shandong Province, China and is one of China’s largest coal producers and coal exporters. Based on coal output per production employee, the company is one of the most efficient underground coal mining enterprises in China.(Press Release) “

Zafgen (NASDAQ:ZFGN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Zafgen, Inc. is a biopharmaceutical company. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprising obesity and hyperphagia in Prader-Willi Syndrome patients, craniopharyngioma-associated obesity, and severe obesity in the general population. Zafgen, Inc. is headquartered in Cambridge, Massachusetts. “

Zte Corp. (OTCMKTS:ZTCOY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ZTE Corporation is engaged in providing telecom equipment and networking solutions to telecom operators. The company offers wireless communications systems, wireline switch and access equipment, optical and data communications equipment, mobile phone handsets, data card products, and telecommunications software systems. It also engages in the production of remote control switch systems, multimedia communications systems, and communications transmission systems. The company also provides technical design, development, consultation, and related services for the research, manufacture and production of mobile communications systems equipment, satellite communications, microwave communications equipment, beepers, computer hardware and software, closed-circuit TVs, microwave communications, automated signal control, computer information processing, process monitoring systems, and fire alarm systems. ZTE Corporation is based in Shenzhen, the People’s Republic of China. “

Receive News & Ratings for Analog Devices Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analog Devices Inc and related companies with MarketBeat.com's FREE daily email newsletter.